BIOMEDICINE AND MEDICAL TECHNOLOGY are crucial for Sweden’s future. Historically, they have also been some of the country’s strengths, with international successes in everything from x-ray technology to drugs for stomach ulcers, pain relief and cardiac regulation. Unique projects have made Flemingsberg the place for new partnerships that lead to discovery and innovation. Within the framework for the Center for Technology in Medicine and Health (CTMH) and Karolinska Institutet Science Park, new innovations are honed for companies with the potential to improve the lives of millions. These centers provide invaluable support and make it easier for successful researchers to take the next step to establishing internationally competitive export companies.
Today, new premises totaling over 1.6 million square feet are being planned for Flemingsberg, space which will give new businesses plenty of room to grow.
HERE IS WHERE NEW, internationally-competitive companies are born and grow. At present, a number of well-known Life Science companies, such as Medivir and KaroBio, exist side-by-side with the incubator that is Karolinska Institutet Science Park. Flemingsberg’s proximity to both healthcare facilities and leading research centers provides the right mix for producing a wealth of successful exports.